169 related articles for article (PubMed ID: 38631847)
21. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphoma in systemic lupus erythematosus: report of 4 cases with ultrastructural studies in 2.
Agudelo CA; Schumacher HR; Glick JH; Molina J
J Rheumatol; 1981; 8(1):69-78. PubMed ID: 7218261
[TBL] [Abstract][Full Text] [Related]
23. Malignancies in systemic lupus erythematosus.
Kiss E; Kovacs L; Szodoray P
Autoimmun Rev; 2010 Feb; 9(4):195-9. PubMed ID: 19643208
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
25. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
26. Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Bernatsky S; Ramsey-Goldman R; Joseph L; Boivin JF; Costenbader KH; Urowitz MB; Gladman DD; Fortin PR; Nived O; Petri MA; Jacobsen S; Manzi S; Ginzler EM; Isenberg D; Rahman A; Gordon C; Ruiz-Irastorza G; Yelin E; Bae SC; Wallace DJ; Peschken CA; Dooley MA; Edworthy SM; Aranow C; Kamen DL; Romero-Diaz J; Askanase A; Witte T; Barr SG; Criswell LA; Sturfelt GK; Blanco I; Feldman CH; Dreyer L; Patel NM; St Pierre Y; Clarke AE
Ann Rheum Dis; 2014 Jan; 73(1):138-42. PubMed ID: 23303389
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.
Rúa-Figueroa Í; Richi P; López-Longo FJ; Galindo M; Calvo-Alén J; Olivé-Marqués A; Loza-Santamaría E; Vicente SP; Erausquin C; Tomero E; Horcada L; Uriarte E; Sánchez-Atrio A; Rosas J; Montilla C; Fernández-Nebro A; Rodríguez-Gómez M; Vela P; Blanco R; Freire M; Silva L; Díez-Álvarez E; Ibáñez-Barceló M; Zea A; Narváez J; Martínez-Taboada V; Marenco JL; de Castro MF; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas JJ; Pecondón Á; Marras C; Carreira P; Bonilla G; Torrente V; Castellví I; Alegre J; Moreno M; Raya E; de la Peña PG; Vázquez T; Aguirre Á; Quevedo V; Pego-Reigosa JM;
Medicine (Baltimore); 2015 Jan; 94(1):e267. PubMed ID: 25569641
[TBL] [Abstract][Full Text] [Related]
28. Childhood-onset systemic lupus erythematosus (cSLE) and malignancy: a nationwide multicentre series review.
Brufatto MZ; Lanças SHS; de Albuquerque Pedrosa Fernandes T; Sallum AME; Campos LMA; Sakamoto AP; Terreri MT; Sztajnbok FR; Bica BERG; Ferriani VPL; de Carvalho LM; Silva CAA; Saad-Magalhaes C
Adv Rheumatol; 2024 Feb; 64(1):13. PubMed ID: 38321580
[TBL] [Abstract][Full Text] [Related]
29. Concomitant manifestation of systemic lupus erythematosus and low-grade non-Hodgkin's lymphoma.
Munzert G; Frickhofen N; Bauditz J; Schreiber S; Herrmann F
Leukemia; 1997 Aug; 11(8):1324-8. PubMed ID: 9264388
[TBL] [Abstract][Full Text] [Related]
30. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.
Torrente-Segarra V; Salman-Monte TC; Rúa-Figueroa Í; Pérez-Vicente S; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ibañez-Ruán J; Horcada L; Sánchez-Atrio A; Montilla C; Rodríguez-Gómez M; Díez-Álvarez E; Martinez-Taboada V; Andreu JL; Fernández-Berrizbeitia O; Hernández-Beriain JA; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Marras C; Bonilla G; Pego-Reigosa JM; ;
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S40-7. PubMed ID: 26575317
[TBL] [Abstract][Full Text] [Related]
31. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER).
Riveros Frutos A; Holgado S; Sanvisens Bergé A; Casas I; Olivé A; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Rúa-Figueroa I;
Rheumatology (Oxford); 2021 Apr; 60(4):1793-1803. PubMed ID: 33106841
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus progressing to non-Hodgkin's lymphoma complicated by fatal hemophagocytic syndrome: case report.
Jeremić I; Dorđević-Kontić S; Nikolić M; Sefik-Bukilica M; Vujasinović-Stupar N; Bonači-Nikolić B
Acta Dermatovenerol Croat; 2012; 20(1):21-6. PubMed ID: 22507470
[TBL] [Abstract][Full Text] [Related]
33. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin's lymphoma in an adolescent with systemic lupus erythematosus.
Efremidis A; Eiser AR; Grishman E; Rosenberg V
Cancer; 1984 Jan; 53(1):142-6. PubMed ID: 6360326
[TBL] [Abstract][Full Text] [Related]
35. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
Suszek D; Górak A; Majdan M
Rheumatol Int; 2020 Oct; 40(10):1625-1629. PubMed ID: 32772131
[TBL] [Abstract][Full Text] [Related]
36. Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network.
Fernández-Garcés M; Haro G; Micó ML
Medicine (Baltimore); 2019 Oct; 98(43):e17489. PubMed ID: 31651851
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of cancer in patients with systemic lupus erythematosus.
Pettersson T; Pukkala E; Teppo L; Friman C
Ann Rheum Dis; 1992 Apr; 51(4):437-9. PubMed ID: 1586239
[TBL] [Abstract][Full Text] [Related]
38. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
39. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
[TBL] [Abstract][Full Text] [Related]
40. Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units.
Abramovich E; Barrett O; Dreiher J; Novack V; Abu-Shakra M
Lupus; 2018 Oct; 27(12):1936-1943. PubMed ID: 30185096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
